Article
Therapy-Induced Senescence: Novel Approaches for Markers Identification
2 Aug 2024
Abstract excerpt
Therapy-induced senescence (TIS) represents a major cellular response to anticancer treatments. Both malignant and non-malignant cells in the tumor microenvironment undergo TIS and may be harmful for cancer patients since TIS cells develop a senescence-associated secretory phenotype (SASP) that can sustain tumor growth. The SASP also modulates anti-tumor immunity, although the immune populations involved and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
